COCH Logo

Envoy Medical, Inc. - Class A Common Stock (COCH) Stock Forecast & Price Prediction

Live COCH Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Medical Devices

$1.54

+0.00 (0.00%)

12 Month Price Forecast For COCH

$1.54
Current Price
$32.79M
Market Cap
4 Ratings
Buy 4
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to COCH Price Forecasts

+484.4%
To High Target of $9.00
+289.6%
To Median Target of $6.00
+224.7%
To Low Target of $5.00

COCH Price Momentum

-3.1%
1 Week Change
+4.8%
1 Month Change
+17.6%
1 Year Change
+7.7%
Year-to-Date Change
-86.6%
From 52W High of $11.46
+32.8%
From 52W Low of $1.16

๐Ÿค” Considering Envoy Medical (COCH)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 5:41 AM UTC

COCH Analyst Ratings & Price Targets

Based on our analysis of 4 Wall Street analysts, COCH has a bullish consensus with a median price target of $6.00 (ranging from $5.00 to $9.00). Currently trading at $1.54, the median forecast implies a 289.6% upside. This outlook is supported by 4 Buy, 0 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Edward Woo at Ascendiant Capital, projecting a 484.4% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

COCH Analyst Consensus

4
Buy
0
Hold
0
Sell

COCH Price Target Range

Low
$5.00
Average
$6.00
High
$9.00
Current: $1.54

Latest COCH Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for COCH.

Date Firm Analyst Rating Change Price Target
Dec 6, 2024 Ascendiant Capital Edward Woo Buy Maintains $9.00
Oct 14, 2024 Brookline Capital Tyler Bussian Buy Initiates $9.00
Sep 3, 2024 Ascendiant Capital Edward Woo Buy Maintains $8.75
Jun 24, 2024 Ascendiant Capital Edward Woo Buy Initiates $8.50
Apr 3, 2024 Lake Street Frank Takkinen Buy Maintains $6.00
Dec 21, 2023 Northland Capital Markets Carl Byrnes Outperform Initiates $0.00
Nov 28, 2023 Lake Street Frank Takkinen Buy Initiates $3.00

Stocks Similar to Envoy Medical, Inc. - Class A Common Stock

The following stocks are similar to Envoy Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Envoy Medical, Inc. - Class A Common Stock (COCH) Financial Data

Envoy Medical, Inc. - Class A Common Stock has a market capitalization of $32.79M with a P/E ratio of -0.6x. The company generates $302,000 in trailing twelve-month revenue with a 0.0% profit margin.

Revenue growth is +7.9% quarter-over-quarter, while maintaining an operating margin of -7,147.1% and return on equity of N/A.

Valuation Metrics

Market Cap $32.79M
Enterprise Value $48.59M
P/E Ratio -0.6x
PEG Ratio -1.4x
Price/Sales 108.6x

Growth & Margins

Revenue Growth (YoY) +7.9%
Gross Margin -233.9%
Operating Margin -7,147.1%
Net Margin 0.0%
EPS Growth N/A

Financial Health

Cash/Price Ratio +5.8%
Current Ratio 0.6x
Debt/Equity -0.5x
ROE N/A
ROA -266.3%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Envoy Medical, Inc. - Class A Common Stock logo

Envoy Medical, Inc. - Class A Common Stock (COCH) Company Overview

About Envoy Medical, Inc. - Class A Common Stock

What They Do

Develops innovative medical technologies for hearing loss.

Business Model

The company generates revenue by providing a range of hearing devices, including personal sound amplification products, hearing aids, and advanced implants. These technologies aim to enhance hearing capabilities and improve the quality of life for individuals with hearing impairments.

Additional Information

Founded in 1995 and headquartered in White Bear Lake, Minnesota, Envoy Medical, Inc. is positioned to transform the hearing industry with its cutting-edge products. The recent name change reflects its commitment to innovation and growth in the hearing health market.

Company Information

Sector

Healthcare

Industry

Medical Devices

Employees

34

CEO

Mr. Brent T. Lucas Esq.

Country

United States

IPO Year

2023

Envoy Medical, Inc. - Class A Common Stock (COCH) Latest News & Analysis

COCH stock latest news image
Quick Summary

Envoy Medical (NASDAQ: COCH) plans to start initial patient enrollment for its pivotal clinical trial of the Acclaim CI cochlear implant in Q1 2025, selecting seven study sites.

Why It Matters

The announcement of clinical trial enrollment for Envoy Medical's Acclaim CI indicates potential revenue growth and product development, which can influence stock performance and investor interest.

Source: Newsfile Corp
Market Sentiment: Neutral
COCH stock latest news image
Quick Summary

The FDA has approved a pivotal trial for a fully implanted cochlear implant, and the AMA has approved CPT codes for an already FDA-approved middle ear implant, signaling growth for the company.

Why It Matters

FDA approval for pivotal trials and CPT code endorsements enhance the companyโ€™s growth prospects, potentially driving revenue and investor interest in the medical device sector.

Source: GlobeNewsWire
Market Sentiment: Neutral
COCH stock latest news image
Quick Summary

A study in Otology & Neurotology highlights early experiences and potential advantages of a new fully implanted cochlear implant, indicating advancements in hearing technology.

Why It Matters

The breakthrough cochlear implant could disrupt the medical device market, driving growth for companies involved in hearing technology and attracting investor interest in innovative healthcare solutions.

Source: GlobeNewsWire
Market Sentiment: Neutral
COCH stock latest news image
Quick Summary

Envoy Medical (NASDAQ: COCH) announced the European Patent Office granted Patent No. 3858425 for its implantable cochlear implant system.

Why It Matters

The grant of the patent enhances Envoy Medical's competitive edge in the hearing health market, potentially boosting revenue and attracting investor interest.

Source: GlobeNewsWire
Market Sentiment: Neutral
COCH stock latest news image
Quick Summary

The Acclaimยฎ Fully Implanted Cochlear Implant presents a new option for hearing loss patients, distinguishing itself from current cochlear implant technology.

Why It Matters

The Acclaimยฎ Fully Implanted Cochlear Implant could capture market share in the healthcare sector, potentially boosting sales and stock prices for the company involved.

Source: GlobeNewsWire
Market Sentiment: Neutral
COCH stock latest news image
Quick Summary

Envoy Medical (NASDAQ: COCH) will present a corporate overview at the LD Micro Main Event XVII from October 28-30, 2024, by CFO David R. Wells in Los Angeles.

Why It Matters

David R. Wells' presentation at a major investor conference could influence Envoy Medical's stock performance, offering insights into company strategy and financial health.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About COCH Stock

What is Envoy Medical, Inc. - Class A Common Stock's (COCH) stock forecast for 2025?

Based on our analysis of 4 Wall Street analysts, Envoy Medical, Inc. - Class A Common Stock (COCH) has a median price target of $6.00. The highest price target is $9.00 and the lowest is $5.00.

Is COCH stock a good investment in 2025?

According to current analyst ratings, COCH has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.54. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for COCH stock?

Wall Street analysts predict COCH stock could reach $6.00 in the next 12 months. This represents a 289.6% increase from the current price of $1.54. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Envoy Medical, Inc. - Class A Common Stock's business model?

The company generates revenue by providing a range of hearing devices, including personal sound amplification products, hearing aids, and advanced implants. These technologies aim to enhance hearing capabilities and improve the quality of life for individuals with hearing impairments.

What is the highest forecasted price for COCH Envoy Medical, Inc. - Class A Common Stock?

The highest price target for COCH is $9.00 from Edward Woo at Ascendiant Capital, which represents a 484.4% increase from the current price of $1.54.

What is the lowest forecasted price for COCH Envoy Medical, Inc. - Class A Common Stock?

The lowest price target for COCH is $5.00 from at , which represents a 224.7% increase from the current price of $1.54.

What is the overall COCH consensus from analysts for Envoy Medical, Inc. - Class A Common Stock?

The overall analyst consensus for COCH is bullish. Out of 4 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $6.00.

How accurate are COCH stock price projections?

Stock price projections, including those for Envoy Medical, Inc. - Class A Common Stock, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.